Minireviews
Copyright ©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Cardiol. Mar 26, 2025; 17(3): 103668
Published online Mar 26, 2025. doi: 10.4330/wjc.v17.i3.103668
Advancements in prenatal diagnosis and management of hypoplastic left heart syndrome: A multidisciplinary approach and future directions
Syed Faqeer Hussain Bokhari, Syed M Faizan Sattar, Umair Mehboob, Muhammad Umais, Muhammad Ahmad, Ahmad Malik, Danyal Bakht, Asma Iqbal, Wahidullah Dost
Syed Faqeer Hussain Bokhari, Syed M Faizan Sattar, Umair Mehboob, Muhammad Umais, Muhammad Ahmad, Ahmad Malik, Danyal Bakht, Asma Iqbal, Department of Medicine and Surgery, King Edward Medical University, Lahore 54000, Punjab, Pakistan
Wahidullah Dost, Curative Medicine, Kabul University of Medical Sciences, Kabul 10001, Kābul, Afghanistan
Author contributions: Bokhari SFH contributed to the conceptualization and design of the study, supervised data collection, critically revised the manuscript, and provided overall guidance throughout the research; Faizan Sattar SM conducted the literature review, participated in data analysis, and contributed significantly to editing the manuscript; Mehboob U assisted in data collection, statistical analysis, and interpretation of findings, and contributed to manuscript preparation and revisions; Umais M provided technical support, contributed to the methodology section, and participated in manuscript proofreading; Faizan Sattar SM and Umais M contributed to drafting the manuscript; Ahmad M assisted in the literature search, organized the data for analysis, and provided input during manuscript revisions; Malik A supported data collection and organization, contributed to writing the results section, and ensured accuracy in reporting; Bakht D contributed to data validation and visualization and provided input on the manuscript’s discussion and conclusion sections; Iqbal A assisted in finalizing the manuscript, ensured adherence to formatting and journal guidelines and reviewed the references for accuracy; Dost W contributed to the review of the manuscript, provided feedback on the discussion section, and ensured clarity in presenting the study’s clinical implications; all authors thoroughly reviewed and endorsed the final manuscript.
Conflict-of-interest statement: The authors report no relevant conflicts of interest for this article.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Wahidullah Dost, Curative Medicine, Kabul University of Medical Sciences, Karte-e-sakhi Kabul, Kabul 10001, Kābul, Afghanistan. wahidullahdost96@gmail.com
Received: November 28, 2024
Revised: February 12, 2025
Accepted: February 27, 2025
Published online: March 26, 2025
Processing time: 114 Days and 22.1 Hours
Core Tip

Core Tip: Congenital heart diseases, including hypoplastic left heart syndrome, are among the most significant fetal malformations due to their high morbidity and mortality rates. Recent advancements in prenatal diagnosis, including fetal echocardiography and imaging techniques, have revolutionized early detection and facilitated informed parental decision-making. Innovative prenatal management strategies, such as fetal aortic valvuloplasty and bioengineering therapies, offer the potential to improve outcomes. Despite advancements, challenges remain in imaging precision, treatment optimization, and genetic understanding of hypoplastic left heart syndrome. A multidisciplinary approach is essential for advancing care and exploring future directions, including stem cell therapy and bioengineered hearts, to enhance survival and quality of life for affected patients.